SCHEMBL7228609

SCHEMBL7228609

CCCn1c(=O)c2[nH]c(-c3ccc(OCC(=O)Nc4ccc(F)cc4)cc3)nc2n(CCC)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 19/20 1.00
ADORA2A P29274 17/20 1.00
ADORA1 P30542 13/20 1.00
ADORA3 P0DMS8 12/20 1.00
CYP2D6 P10635 1/20 0.82
CYP2C9 P11712 1/20 0.82
CYP2C19 P33261 1/20 0.82
KDM4E B2RXH2 1/20 0.81
LMNA P02545 1/20 0.81
CYP1A2 P05177 1/20 0.81
CYP3A4 P08684 1/20 0.81
THRB P10828 1/20 0.81
BLM P54132 1/20 0.81
PMP22 Q01453 1/20 0.81
NPSR1 Q6W5P4 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7223187 0.91 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7228603 0.91 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7222372 0.91 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7220779 0.91 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7220653 0.91 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL1223972 0.90 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7228294 0.90 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
Water SCHEMBL15690379 0.90 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7221366 0.90 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6
SCHEMBL7219818 0.90 ADORA2B (1.00) ADORA2BADORA2AADORA1ADORA3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545002-B1 Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy UNIVERSITY OF VIRGINIA PATENT FOUNDATION 2003-04-08 US disclosed